Study finds erectile dysfunction drugs linked to lower Alzheimer’s risk

Post author:
Post published:February 12, 2024
Post category:uncategorized

Researchers evaluated the effect of phosphodiesterase-5 inhibitor (PDE5I) initiation compared to non-use and Alzheimer’s disease development risk among males suffering from erectile dysfunction.

Empowering individuals with knowledge, fostering healthier lifestyles, and fostering a community dedicated to diabetes awareness and prevention. Together, we’re shaping a healthier future.

Helpful Links

Subscribe To Us

By submitting via this part of the website you are granting us permission to store and process your data according to our Standard privacy policy

UPCOMING EVENTS

You Might Also Like

New method predicts sepsis and organ failure in children

Study confirms the mental health benefits of weight training for older individuals

Exploring the intersection: Cardiovascular mortality trends among Alzheimer’s patients in the U.S.

Helpful Links

Subscribe To Us